Please confirm both statements below to enter the site
Peer-reviewed literature supporting the use of tirzepatide for the patient condition
In research, Epithalon has been associated with telomere lengthening, reduced agerelated disease markers, and improved survival in older populations, but these findings are not guaranteed and come from limited cohorts
[5] Practical Considerations for Clinical Use Anyone considering BPC-157 as part of a health or longevity protocol should approach it with the same framework applied to any emerging therapy: define the target outcome, select the administration route supported by the best evidence for that target, start at a conservative dose, and monitor response systematically rather than anecdotally
For skin, hair, and broader anti-ageing repair goals rather than acute injury, GHK-Cu for Wound Healing and Recovery covers a copper-peptide alternative with a different mechanism
Research Status: Tirzepatide is widely studied with extensive Phase 3 data (SURMOUNT trials)